![]()
| Assessed the technical and economic feasibility of several concepts for single-use endoscopes for a supplier of minimally invasive medical devices. | |
| Tested the market potential, identified specific clinical indications, and sized the available U.S. market for a new venous access device intended for power injection of contrast agents for contrast-enhanced computed tomography (CT) for a producer of infusion devices. | |
| For a producer of laboratory tools for drug discovery, characterized market conditions and future demand for equipment used by pharmaceutical and biotechnology firms in combinatorial chemistry for high-throughput applications. | |
| For a leading producer of surgical products, identified high-return investment opportunities in tissue engineering, including cell therapy, gene therapy, stem cells, scaffolds, encapsulation, tissue regeneration, immunotolerance, cryopreservation and transplantation techniques. | |
| For a laboratory equipment company seeking to form a clinical products business, surveyed opportunities in point-of-care breath testing. Following a broad initial survey of potential clinical applications, our work focused on assessing commercial opportunities, competitive threats, partnering prospects and market entry requirements in clinical diagnostics and monitoring of digestive conditions. | |
| Evaluated the strategies and business plans of a young company offering high-value life science research and drug development reagents; suggested methods to improve business growth prospects and provided fundraising support. | |
| Assessed the clinical and commercial viability of a proposed new family of central venous catheters for a broad-range medical device supplier. | |
| Compiled a situation analysis of opportunities in fall detection, prevention, and protection among elderly and disabled persons for a client firm active in real-time remote subscriber monitoring and support services as part of a corporate diversification initiative. | |
| For a medical device supplier, identified relevant medical procedures and assessed the associated Medicare reimbursement landscape in detail for targeted applications in otolaryngology (ENT). | |
| For a leading producer of disposable wound closure and wound drainage products, supported the CEO and his management team in developing a new-product strategy for growth with continued profitability, utilizing existing channels of distribution. | |
| For a leading producer of laboratory centrifuges, supported formulation of a growth strategy by identifying and assessing a wide variety of new-product opportunities. | |
| Identified business opportunities in digital and film-based radiography for a provider of mammography quality control products. | |
| For a venture capital firm, assessed potential research applications and associated business potential of university innovations in laser/optical tweezers and traps. | |
| For an offshore plastics manufacturer, identified and assessed opportunities in polymeric devices for drug discovery and diagnostics. Applications in microfluidics, protein microarrays and value-added microplates were investigated. | |
| For a producer of vascular access devices, gauged the opportunity for a new access device intended for use with implanted infusion ports for chemotherapy administration. | |
| Identified growth opportunities in the diagnosis and treatment of gastrointestinal disorders for a supplier of ostomy and wound care products. | |
| Assessed opportunities in the manufacture of diagnostic test strips (biosensors) for a provider of high-volume specialty coating services. | |
| Discovered, analyzed and ranked diversification opportunities in power semiconductors for a leading producer of discrete semiconductor devices. |
©1998-2008 Trilogy Associates. All rights reserved.
Return to Home Page.